Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation)
Study Identifier
P12-077
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
The survey will be conducted with regard to the following aspects of treatment with Humira (adalimumab) in patients with psoriasis vulgaris and psoriatic arthritis receiving this drug:
- unknown adverse drug reactions, especially clinically significant adverse reactions
- incidence and conditions of occurrence of adverse reactions in the clinical setting
- factors that may affect the safety and effectiveness of Humira.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 41606
Aichi, Japan
Status
Not applicable
Location
Site Reference ID/Investigator# 41769
Aichi, Japan
Status
Not applicable
Location
Site Reference ID/Investigator# 41810
Aichi, Japan
Status
Not applicable
Location
Site Reference ID/Investigator# 56131
Aichi, Japan
Status
Not applicable
Location
Site Reference ID/Investigator# 56251
Aichi, Japan
Status
Not applicable
Location
Site Reference ID/Investigator# 56252
Aichi, Japan
Status
Not applicable
Showing {first} - {last} of {total} Results